Applications of Demecarium Bromide in Industrial Manufacturing

As an established manufacturer of high-purity Demecarium Bromide, we support pharmaceutical and biochemical industries worldwide by supplying a critical ingredient for specialized formulations. Our production integrates stringent quality control measures to align with current global regulatory expectations. The following scenarios showcase real-world industrial applications of our material across compliant downstream markets.

1. Ophthalmic Antiglaucoma Preparations

Demecarium Bromide serves as an essential quaternary ammonium cholinesterase inhibitor for pressure-reducing ophthalmic medications, particularly in the treatment of chronic open-angle glaucoma. Pharmaceutical companies incorporate it into sterile, multi-dose solution formulations following precise concentrations to prolong its intraocular activity and maintain sustained reduction of intraocular pressure. These manufacturing environments demand validated sterilization and aseptic filling operations to ensure stability and patient safety throughout shelf life.

Industry compliance standards

• USP Monograph for Demecarium Bromide Ophthalmic Solutions
• European Pharmacopoeia (Ph. Eur.) 10.0
• 21 CFR Part 210/211 (US cGMP)
• EU GMP Annex 1 (Sterile Medicinal Products)

Typical usage ratio

• 0.125% to 0.25% w/v in aqueous ophthalmic solution; final concentration determined by desired clinical performance per batch and prescribing data

Downstream process integration

• Incorporation into final solution via direct weighing before sterile filtration, followed by aseptic filling into multi-dose containers

Final product types

• Prescription antiglaucoma eye drops
• Hospital-use intraocular solutions
• Specialty ophthalmology unit dose vials

2. Veterinary Ophthalmology Solutions

Animal pharmaceutical manufacturers use Demecarium Bromide in topical eye medications formulated for canine and equine patients suffering from primary glaucoma or as adjunctive glaucoma therapy. The process demands accurate compound weighing and mixing under strict veterinary pharmaceutical controls, along with batch-specific dosing strategies to minimize systemic absorption risks while maintaining efficacy for the target species.

Industry compliance standards

• FDA Center for Veterinary Medicine (CVM) Guidance for Industry #185 (Veterinary Drug Manufacturing)
• VICH GL9 (Good Manufacturing Practice for Veterinary Products)
• Ph. Eur. Veterinary monographs, when applicable
• ISO 9001:2015 Quality Management System

Typical usage ratio

• 0.25 mg/mL (0.025% w/v) final concentration, with adjustment based on animal size and species-specific response observed in stability and safety studies

Downstream process integration

• Weighed into bulk solution prior to sterile filtration; solution then filled into sterile dropper containers for veterinary applications

Final product types

• Veterinary prescription glaucoma eye drops
• Single-use veterinary ocular solution vials

3. Preclinical Research Reagents for Cholinesterase Inhibition

Contract research organizations and pharmaceutical laboratories use Demecarium Bromide as a reference substance and functional tool for in vitro and in vivo studies related to cholinesterase enzyme activity. Here, material traceability and purity verification are critical, especially for regulated GLP facility operations. The compound is diluted from high-purity stock solutions to generate working concentrations, and must be integrated into experimental setups with repeatable performance for assay validation, animal model administration, or control group benchmarking.

Industry compliance standards

• OECD Principles of Good Laboratory Practice
• 21 CFR Part 58 (US GLP regulations)
• ICH Q7 (for API starting materials in research context)
• ISO/IEC 17025:2017 (Testing and Calibration Laboratories)

Typical usage ratio

• 5 nM to 100 μM working solutions for enzyme inhibition assays; in vivo rodent models range 0.001–0.01 mg/kg, with dilution based on targeted inhibitory profile

Downstream process integration

• Dissolved from solid in aqueous buffer or physiological saline immediately before serial dilution and application to assay plates or animal subjects

Final product types

• Preclinical assay research kits
• Reference standards for enzyme studies
• In vivo functional testing injectables

4. Reference Standard Supplies for Pharmaceutical Quality Control

Pharmaceutical manufacturers and contract testing laboratories require high-purity Demecarium Bromide as an analytical standard for quality control of eye drop finished products. The material enters processes after manufacturing, supporting HPLC quantification, identity confirmation, and stability batch analyses as dictated by regulatory dossiers. Each batch supplied for QC reference standard meets pharmacopeial criteria for purity, traceability, and labeling to maintain analytical consistency across regulated environments.

Industry compliance standards

• USP, EP, and JP reference standard protocols
• 21 CFR Part 211 Subpart I (Laboratory Controls)
• ISO/IEC 17025 for analytical reference materials
• WHO Technical Report Series 996 Annex 3 (Good Practices for Pharmaceutical Quality Control Laboratories)

Typical usage ratio

• pharmaceutical QC labs prepare 0.5–1.0 mg/mL calibration solutions; mass of standard weighed according to validated assay requirements and standard operating procedures

Downstream process integration

• Reference material dissolved and diluted in appropriate chromatographic mobile phase or buffer during sample quantitation workflows, stability studies, and process validation runs

Final product types

• Certified analytical reference kits for in-house QC
• Standardized assay control samples for regulatory submission data